T863 | T863 : Inhibitor of DGAT1
RATINGS:
Cellular Use: (1 reviews)

In Model Organisms: (1 reviews)
Control Compounds

Probe Summary

Targets Biochemical/Biophysical Potency Cellular Potency
DGAT1
  • IC50:15 nM
  • IC50:4 nM
Inhibitor
up to 100 nM

Selectivity

In Vitro Selectivity Assessment
Selectivity Assessment Description:
Selective against DGAT2: 3.7 %inhibition @ 10 uM compound and ACAT-1 IC50 = 12000 nM

Potency
Cellular
In Vitro

DGAT1

Mode of Action: Inhibitor

Structure-Activity-Relationship data available? No

DOI Reference: 10.1021/jm801507v

In Vivo Validations

Rat
Dose: 1-3 mg/Kg
Route of delivery: Intravenous, Oral
Plasma half life: 3.0 (IV), 5.6 (PO) h
Systemic clearance: 5.2 mL/min/kg
Bioavailability: 100%
Volume of Distribution at Steady-State: 0.69 L/Kg

DOI Reference: 10.1021/jm801507v

Dog
Dose: 1-3 mg/Kg
Route of delivery: Intravenous, Oral
Plasma half life: 3.9 (IV), 2.8 (PO) h
Systemic clearance: 12 mL/min/kg
Bioavailability: >100%
Volume of Distribution at Steady-State: 2.0 L/Kg

DOI Reference: 10.1021/jm801507v

Chemical Information

Molecular Formula C22H26N4O3
SMILEs CC1(C)Oc2ncnc(N)c2N=C1c1ccc([C@H]2CC[C@H](CC(=O)O)CC2)cc1
InChI InChI=1S/C22H26N4O3/c1-22(2)19(26-18-20(23)24-12-25-21(18)29-22)16-9-7-15(8-10-16)14-5-3-13(4-6-14)11-17(27)28/h7-10,12-14H,3-6,11H2,1-2H3,(H,27,28)(H2,23,24,25)/t13-,14-
Molecular weight 394.20 Da
AlogP 4.099100000000003
HBond acceptors 7
HBond donors 3
Atoms 55

References

Publications

Cross References

Vendors

Note: This is not an exhaustive list and does not indicate endorsement by the portal.

Expert Reviews


(on 14 Jun 2022)
Cellular Use Rating
In Model Organisms
Caution should be taken that the reported bioavailability is based on the acyl glucuronide metabolite and not the parent compound.
Note: The Chemical Probes Portal only endorses compounds as chemical probes for use as specific and selective modulators of the proposed target if they receive three or more (3-4) stars. Read more about our evaluation criteria